| Neurological Disease |
Schizophrenia |
3.24E-04 |
ATP1A2, CELF2, CHL1, CLDN5, CNTNAP2, DAB1, FOXP2, GRM3, NELL2, NTF3, SCD5, TAC1, TTR |
| Neurological Disease |
malformation of brain |
3.94E-04 |
ARX, CNTNAP2, EOMES, MEF2C, VLDLR |
| Neurological Disease |
type 1 lissencephaly |
9.70E-04 |
ARX, VLDLR |
| Neurological Disease |
seizure disorder |
2.04E-03 |
ARX, ATP1A2, CNTNAP2, GPR98, KCNQ3, MEF2C, PRICKLE1, TAC1 |
| Neurological Disease |
speech and language disorders |
3.45E-03 |
ARX, FOXP1, FOXP2 |
| Neurological Disease |
epilepsy |
4.12E-03 |
ARX, ATP1A2, CNTNAP2, KCNQ3, MEF2C, PRICKLE1, TAC1 |
|
Category
|
Functions Annotation
|
p-Value
|
Molecules (decreased in T-iPSC neurons)
|
| Cellular Development |
differentiation of tumor cell lines |
1.29E-06 |
ASCL1, BTG2, CCND1, DLK1, HOXA5, JAG1, KLF4, NOTCH1, NTRK2, PRKCD, PRKD3, WNT7A, ZBTB16 |
| Cellular Growth andProliferation |
proliferation of epithelial cells |
1.14E-05 |
CCND1, ITGB8, NOTCH1, PAX2, PRKCD, PTPRZ1, RGS4, VIP, WNT7A |
| Cellular Development |
differentiation of cells |
1.40E-05 |
ASCL1, BTG2, CCND1, DLK1, DLL1, FRZB, HOXA5, HOXA7, HOXA9, HS6ST1, JAG1, KLF4, MAL, NOTCH1, NTRK2, PRKCD, PRKD3, PTCH1, RGS4, TESC, WNT7A, ZBTB16 |
| Psychological Disorders |
Anxiety Disorders |
1.84E-05 |
ADRA1A, CA14, CACNA2D3, GABRR1, GAD2, OPRM1, SLC32A1, SLC6A1 |
| Neurological Disease |
seizures |
2.44E-05 |
ANKRD6, CA14, CACNA2D3, CYYR1, GABRR1, GAD1, GAD2, KLF10, LAMP5, PCSK1, SLC32A1, SLC6A1 |
